Arcturus Therapeutics Holdings (ARCT) Tax Provisions (2022 - 2025)
Arcturus Therapeutics Holdings (ARCT) posted Tax Provisions of -$17814.0 for Q4 2025, down 545.35% on a QoQ basis from $4000.0 in Q2 2025, and down 345.35% year-over-year from $7260.6 in Q4 2024.
Arcturus Therapeutics Holdings (ARCT) Tax Provisions (2022 - 2025) Analysis & Trends
Arcturus Therapeutics Holdings' Tax Provisions history runs 4 years deep, the most recent figure standing at -$17814.0 for Q4 2025.
- Quarterly Tax Provisions fell 345.35% year-over-year to -$17814.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$13814.0 (up 73.94% YoY) and the FY2025 annual result came in at -$13814.0, down 245.35% from the prior year.
- Tax Provisions was -$17814.0 for Q4 2025 at Arcturus Therapeutics Holdings, down from $4000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $900000.0 in Q3 2023 and bottomed at -$217000.0 in Q3 2024.
- A 4-year average of $172562.4 and a median of $100000.0 in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2024 — Tax Provisions surged 257.28% — and 2025, when it tumbled 345.35%.
- Arcturus Therapeutics Holdings' Tax Provisions stood at $100000.0 in 2022, then surged by 162.0% to $262000.0 in 2023, then slumped by 101.53% to -$4000.0 in 2024, then tumbled by 345.35% to -$17814.0 in 2025.
- Business Quant data shows ARCT's Tax Provisions at -$17814.0 in Q4 2025, $4000.0 in Q2 2025, and -$4000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arcturus Therapeutics Holdings | 164.57 Mn | -46.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -17,814.00 |
| Jun 30, 2025 | 4,000.00 |
| Dec 31, 2024 | -4,000.00 |
| Sep 30, 2024 | -217,000.00 |
| Jun 30, 2024 | -200,000.00 |
| Mar 31, 2024 | 368,000.00 |
| Dec 31, 2023 | 262,000.00 |
| Sep 30, 2023 | 900,000.00 |
| Jun 30, 2023 | 600,000.00 |
| Mar 31, 2023 | 103,000.00 |
| Mar 31, 2022 | 100,000.00 |